Skip to main
DXCM

DexCom (DXCM) Stock Forecast & Price Target

DexCom (DXCM) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 55%
Buy 32%
Hold 9%
Sell 5%
Strong Sell 0%

Bulls say

DexCom is a leader in the growing market of continuous glucose monitoring systems, with a strong management team and a scalable business model. This outlook is supported by the company's latest clinical trial data, which showed significant improvements in A1c and time in range for type 2 diabetic patients using the company's CGM system. While pricing headwinds may exist in the future, the potential for increased adoption by non-intensive type 2 patients and expansion in international markets should drive significant upside for DexCom.

Bears say

DexCom is facing potential challenges in increasing their CGM penetration in the US market, and the company's competitive advantage may be reduced by competition from other products. Furthermore, future product releases may face delays due to regulatory barriers, and the company's stock may continue to trade at a high premium multiple, posing risks to potential investors.

DexCom (DXCM) has been analyzed by 22 analysts, with a consensus rating of Buy. 55% of analysts recommend a Strong Buy, 32% recommend Buy, 9% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DexCom and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DexCom (DXCM) Forecast

Analysts have given DexCom (DXCM) a Buy based on their latest research and market trends.

According to 22 analysts, DexCom (DXCM) has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.05, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.05, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DexCom (DXCM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.